Liquid Biopsy Proteomics in Ophthalmology
Journal of Proteome Research · 2024
DOI: 10.1021/acs.jproteome.3c00756 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Julian Wolf und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Surgery Laboratory, Stanford University, Palo Alto, California 94305, United States. Hauptthemen laut MEDLINE: Ophthalmology. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, NICHD NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Minimally invasive liquid biopsies from the eye capture locally enriched fluids that contain thousands of proteins from highly specialized ocular cell types, presenting a promising alternative to solid tissue biopsies. The advantages of liquid biopsies include sampling the eye without causing irreversible functional damage, potentially better reflecting tissue heterogeneity, collecting samples in an outpatient setting, monitoring therapeutic response with sequential sampling, and even allowing examination of disease mechanisms at the cell level in living humans, an approach that we refer to as TEMPO (Tracing Expression of Multiple Protein Origins). Liquid biopsy proteomics has the potential to transform molecular diagnostics and prognostics and to assess disease mechanisms and personalized therapeutic strategies in individual patients. This review addresses opportunities, challenges, and future directions of high-resolution liquid biopsy proteomics in ophthalmology, with particular emphasis on the large-scale collection of high-quality samples, cutting edge proteomics technology, and artificial intelligence-supported data analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Surgery Laboratory, Stanford University, Palo Alto, California 94305, United States.
- Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California 94303, United States.
- Departments of Physiology and Pharmacology & Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.
- Department of Pediatrics, University of Iowa, Iowa City, Iowa 52242, United States.
- Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, United States.
ORCID-Profile: Julian Wolf, Antoine Dufour, Vinit B Mahajan
Förderung
- NEI NIH HHS
- NICHD NIH HHS
- National Eye Institute
- Research to Prevent Blindness
- VitreoRetinal Surgery Foundation
- Translational Research and Applied Medicine, School of Medicine, Stanford University
- The Alan and Irene Adler Ocular Cancer Research Initiative
- Stanford Center for Optic Disc Drusen
Zitieren
APA
Wolf, J., Franco, J. A., Yip, R., Dabaja, M. Z., Velez, G., Liu, F., Bassuk, A. G., Mruthyunjaya, P., Dufour, A., & Mahajan, V. B. (2024). Liquid Biopsy Proteomics in Ophthalmology. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.3c00756
Vancouver
Wolf J, Franco JA, Yip R, Dabaja MZ, Velez G, Liu F, et al. Liquid Biopsy Proteomics in Ophthalmology. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.3c00756
BibTeX
@article{Wolf2024,
author = {Wolf, Julian and Franco, Joel A and Yip, Rui and Dabaja, Mohamed Ziad and Velez, Gabriel and Liu, Fei and Bassuk, Alexander G and Mruthyunjaya, Prithvi and Dufour, Antoine and Mahajan, Vinit B},
title = {Liquid Biopsy Proteomics in Ophthalmology},
journal = {Journal of Proteome Research},
year = {2024},
doi = {10.1021/acs.jproteome.3c00756}
}
EUVIMED